Welcome to Markets Desk, your midday read on what's moving money and markets right now.
The semiconductor story is bigger than any single ETF, but how you own it matters. The iShares Semiconductor ETF, SOXX, offers pure-play exposure to chipmakers, but at thirty-four basis points annually. State Street's XLK spreads that bet across broader technology at just eight basis points, giving cost-conscious investors a reason to think twice before going all-in on silicon alone.
Speaking of silicon, the AI data center build-out is quietly eating into one of the bull market's own foundations. The infrastructure spending required to power artificial intelligence is cannibalizing capital that might otherwise flow into the broader economy. Markets hit new highs on the AI trade, but the internal tension between building the machine and feeding everything else is a dynamic investors cannot ignore.
And then there's Novo Nordisk, where a single data point is reshaping the bear case almost entirely. Eighty percent of patients taking the pill-form Wegovy had never used a weight loss drug before. That is not a loyalty story, that is a market expansion story, suggesting the addressable population for GLP-one therapy is far larger than even the bulls had modeled.
That's the tape. Markets Desk, signing off the floor.
